Atlas Trials

the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer

Clinical trial NCT05131243 · UNKNOWN

Trial details

NCT number
NCT05131243
Sponsor
Fujian Cancer Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Colorectal Cancer Stage IIColorectal Cancer Stage III
Start date
2021-12-01
Primary completion
2023-05-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.